Related Experiment Video
Updated: Nov 17, 2025

Mosaic Zebrafish Transgenesis for Functional Genomic Analysis of Candidate Cooperative Genes in Tumor Pathogenesis
Published on: March 31, 2015
Revertant somatic mosaicism as a cause of cancer
Toshiya Inaba1, Akiko Nagamachi1
1Department of Molecular Oncology and Leukemia Program Project, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
Abstract:
Revertant (somatic) mosaicism is a spontaneous correction of a causative mutation in patients with congenital diseases. A relatively frequent event, revertant mosaicism may bring favorable outcomes that ameliorate disorders, and is therefore called "natural gene therapy." However, it has been revealed recently that "overcorrection" of inherited bone marrow failure in patients with sterile alpha motif domain containing 9 (SAMD9)/9L syndromes by revertant mosaicism induces myelodysplastic syndrome (MDS) with monosomy 7 that occasionally proceeds to acute myelogenous leukemia (AML). In this review, we interpret very complex mechanisms underlying MDS/AML in patients with SAMD9/9L syndromes. This includes multiple myeloid tumor suppressors on the long arm of chromosome 7, all of which act in a haploinsufficient fashion, and a difference in sensitivity to interferon between cells carrying a mutation and revertants. Overcorrection of mutants by somatic mosaicism is likely a novel mechanism in carcinogenesis.
Insights
Revertant mosaicism, a natural gene correction, can paradoxically cause myelodysplastic syndrome and leukemia in SAMD9/9L syndromes through overcorrection. This study explores the complex mechanisms behind this "overcorrection" phenomenon in carcinogenesis.
Area of Science:
- Genetics
- Oncology
- Molecular Biology
Background:
- Revertant mosaicism spontaneously corrects mutations, acting as 'natural gene therapy' for congenital diseases.
- However, overcorrection in SAMD9/9L syndromes can induce myelodysplastic syndrome (MDS) and acute myelogenous leukemia (AML).
Purpose of the Study:
- To interpret the complex mechanisms underlying MDS/AML development in SAMD9/9L syndromes due to revertant mosaicism.
- To highlight overcorrection by somatic mosaicism as a novel mechanism in carcinogenesis.
Main Methods:
- Review of existing literature on SAMD9/9L syndromes, revertant mosaicism, MDS, and AML.
- Analysis of genetic and cellular mechanisms involving chromosome 7 tumor suppressors and interferon sensitivity.
Main Results:
- Overcorrection by revertant mosaicism in SAMD9/9L syndromes leads to MDS with monosomy 7, potentially progressing to AML.
- Mechanisms involve haploinsufficiency of multiple myeloid tumor suppressors on chromosome 7 and differential interferon sensitivity.
Conclusions:
- Somatic mosaicism-induced overcorrection represents a novel pathway to carcinogenesis.
- Understanding these mechanisms is crucial for managing SAMD9/9L syndromes and preventing hematologic malignancies.
Related Concept Videos
Cancers Originate from Somatic Mutations in a Single Cell
Induced Pluripotent Stem Cells
Somatic...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Mismatch Repair
Mechanisms of Retrovirus-induced Cancers

